Compound
D1279 | A23187
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| TRANSPORT OF PROTONS BUT NOT CHARGE (CA2+ OR MG2+) | affect | 201 | ||||||
| TRANSPORT OF PROTONS BUT NOT CHARGE (CA2+ OR MG2+) | affect | 203 | ||||||
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
 |
Warning |
Aggregated GHS information provided by 41 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H315 (95.12%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (95.12%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (95.12%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure Respiratory tract irritation] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl), (6S-(6-alpha(2S*,3S*),8-beta(R*),9-beta,11-alpha))- | 4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl)-1,7-dioxaspiro(5.5)undec-2-yl)methyl)-, (6S-(6alpha(2S*,3S*),8beta(R*),9beta,11alpha))- | 5-(Methylamino)-2-[[2R,3R,6S,8S,9R,11R)-3,9,11-trimethyl-8-[(1S)-1-methyl-2-oxo-2-(1H-pyr rol-2-yl)-ethyl]-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-4-benzoxazolecarboxylic acid |
| 5-(methylamino)-2-({(2S,3S,8S,9R,11R)-3,9,11-trimethyl-8-[1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undec-2-yl}methyl)-1,3-benzoxazole-4-carboxylic acid | 5-(methylamino)-2-[[(2S,3R,5R,8S,9S)-3,5,9-trimethyl-2-[1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid | 5-(methylamino)-2-[[(3S,4S,7R,9R,10S)-3,7,9-trimethyl-10-[1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]-5,11-dioxaspiro[5.5]undecan-4-yl]methyl]-1,3-benzoxazole-4-carboxylic acid |
| 52665-69-7 | 6S-[6.alpha.(2S*,3S*),8.beta.(R*),9.beta.11. alpha.]-5-(Methylamino)-2-[[3,9,11-trimethyl-8- [1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]-1,7- dioxaspiro[5,5]undec-2-yl]methyl-4- benzoxazolecarboxylic aci | A 23187 |
| A-23187 | A23187 | A23187, free acid |
| Antibiotic A23187 | BRD-A19134330-001-03-8 | BSPBio_001576 |
| Bio1_000028 | Bio1_000517 | Bio1_001006 |
| Bio2_000296 | Bio2_000776 | C11309 |
| C29H37N3O6 | CBiol_001742 | CCG-208023 |
| CCG-208154 | CHEBI:3305 | CHEMBL1434752 |
| Calcimycin | Calcium ionophore A23187 | Calcium ionophore;4-Benzoxazolecarboxylic acid, 5-(methylamino)-2-[[3,9,11-trimethyl-8-[1-methyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-, [6S-[6a(2S*,3S*),8ss(R*),9ss,11a]]- |
| DTXSID1040405 | DivK1c_000618 | EINECS 258-084-1 |
| HMS1361O18 | HMS1791O18 | HMS1989O18 |
| HMS3402O18 | HMS501O20 | IDI1_000618 |
| IDI1_034046 | Ionophore A23187 | KBio1_000618 |
| KBio2_000296 | KBio2_002533 | KBio2_002864 |
| KBio2_005101 | KBio2_005432 | KBio2_007669 |
| KBio3_000591 | KBio3_000592 | KBioGR_000296 |
| KBioSS_000296 | KBioSS_002542 | LS-42155 |
| NCGC00161647-01 | NINDS_000618 | Q27106018 |
| SCHEMBL258988 | SMP2_000029 | Spectrum_001976 |
| UPCMLD-DP093 | UPCMLD-DP093:001 | UPCMLD-DP093:002 |
| UPCMLD-DP093:003 |
| CAS Number | 52665-69-7, 79646-37-0 |
| PubChem Compound | 11957499 |